PDIA5 expression level was higher in GBM (WHO grade IV) compared to LGG (WHO grade II and grade III) (Figure 1C), and it was elevated in malignant histopathologic gliomas (Supplementary Figure S1D). The gene discussed is PDIA5; the disease is central nervous system cancer.